OraSure Technologies, Inc. (OSUR) Stock: What Does the Chart Say Friday?

Overall market sentiment has been high on OraSure Technologies, Inc. (OSUR) stock lately. OSUR receives a Bullish rating from InvestorsObserver Stock Sentiment Indicator.

OraSure Technologies, Inc. has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on OSUR!

See Full OSUR Report

What is Stock Sentiment?

In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company. Recent trends are a good indicator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive. InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend. Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .

What's Happening With OSUR Stock Today?

OraSure Technologies, Inc. (OSUR) stock is down -2.19% while the S&P 500 has gained 0.48% as of 2:16 PM on Friday, Dec 1. OSUR has fallen -$0.16 from the previous closing price of $7.32 on volume of 210,595 shares. Over the past year the S&P 500 is up 12.49% while OSUR has gained 42.06%. OSUR earned $0.67 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 10.74.

More About OraSure Technologies, Inc.

OraSure Technologies is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets most of its sales from the molecular solutions business, derived mainly from customers in the United States. Click Here to get the full Stock Report for OraSure Technologies, Inc. stock.